Yale Liver Cancer Symposium 2019

liver image

Yale Liver Cancer Symposium 2019: The Changing Landscape of Hepatocellular Carcinoma (HCC) Management

Yale West Campus, Conference Center
Friday, March 1, 2019
7:30am - 5:00pm

This Symposium is supported by: Merck, Eisai Co., Ltd., and The Norbert Schnog Endowment.

Course Director: 
Mario Strazzabosco, MD, PhD, Clinical Program Leader, Smilow Cancer Hospital Liver Cancer Program

For information, please call (203) 785-2229. To register, click here 


7:30 am Registration and Breakfast

8:00 Opening Remarks
Lori Pickens, MHA, Senior Vice President and Executive Director, Smilow Cancer Hospital

8:15 Session One: The Changing Landscape of Hepatocellular

Carcinoma (HCC) Management—Between Reality and Predictions
Moderators: Mario Strazzabosco, MD, PhD, Professor of Medicine; Clinical Program Leader, Liver Cancer Program; Deputy Director, Yale Liver Center
Rob Goodman , MBBCh, MBA, BMSc, Chairman and Professor of Radiology and Biomedical Imaging
Tamar Taddei, MD, Associate Professor of Medicine (Digestive Diseases)

and Biomedical Imaging

Big Data: Artificial Intelligence Solutions for Decision Making
Julius Chapiro, MD, Associate Research Scientist, Radiology and
Biomedical Imaging

Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases)


10:15 Break

Stacey Stein, MD, Assistant Professor of Medicine (Medical Oncology)


10:55 Session Two: The Patient With Early Stage Disease:What is the First Line Therapy?

Moderator: Nita Ahuja, MD, MBA, Chair, Department of Surgery; William H. Carmalt Professor of Surgery

Kimberly Johung, MD, PhD, Assistant Professor of Therapeutic Radiology; Director, Gastrointestinal Radiotherapy Program

Charles Cha, MD, FACS, Associate Professor of Surgery (Oncology and Gastrointestinal)

Jeffrey Pollak, MD, Robert I. White, Jr., Professor of Radiology and Biomedical Imaging

Michael Schilsky, MD, Professor of Medicine (Digestive Diseases);
Medical Director, Adult Liver Transplant Center

David Mulligan, MD, FACS, Professor of Surgery (Transplant); Section Chief, Transplantation Surgery and Immunology


1:00 pm Lunch

2:00 Session Three: The Patient With Intermediate Stage Disease: New Frontiers

Moderator: Sukru Emre, MD, Professor of Surgery (Transplant) and of Pediatrics

Kevin Kim, MD, Professor of Radiology and Biomedical Imaging; Professor of Medicine (Medical Oncology)

Todd Schlachter, MD, Assistant Professor, Radiology and Biomedical Imaging


3:20 Break

3:40 Session Four: The Patient with Advanced Stage Disease

Michael Nathanson, MD, PhD, Gladys Phillips Crofoot Professor of Medicine (Digestive Diseases); Professor of Cell Biology; Director, Yale Liver Center

Raj Ayyagari, MD, Assistant Professor of Radiology and Biomedical Imaging

Andrew Putnam, MD, Assistant Professor of Medicine; Smilow Cancer Hospital Palliative Care Program


4:40 Putting it all Together

5:00 Conclude

The Yale School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.

State-of-the-Art Transarterial Chemoembolization - 30 Years of TACE

March 1, 2019: Yale Liver Cancer Symposium